Sanofi Recalls 9,380 Vials of Fludara
Sanofi, a unit of Genzyme, has issued a recall for 9,380 vials of Fludara because the leukemia drug may have a “lack of assurance of sterility”, according to U.S. regulators. Bloomberg reports that the drug recall was prompted after U.S. and European regulators discovered violations at Boehringer Ingelheim GmbH’s Ben Venue Laboratories, the drug’s manufacturing plant. While Genzyme stated that “no issue” had been